Suppr超能文献

协同失调性排便:炎症性肠病缓解时持续性症状的可治疗病因。

Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission.

机构信息

Division of Gastroenterology and Hepatology, Medical College of Wisconsin, 9200 W. Wisconsin Ave., Milwaukee, WI, 53226, USA,

出版信息

Dig Dis Sci. 2013 Dec;58(12):3600-5. doi: 10.1007/s10620-013-2850-3. Epub 2013 Sep 12.

Abstract

BACKGROUND

Introduction of biologic agents in inflammatory bowel disease (IBD) has increased the likelihood of disease remission. Despite resolution of active inflammation, a subset of IBD patients report persistent defecatory symptoms.

AIM

To evaluate a group of patients with inflammatory bowel disease with suspected functional defecatory disorders, by use of anorectal manometric testing and subsequent biofeedback therapy.

METHODS

A group of IBD patients with persistent defecatory problems despite clinical improvement were included in this study. These patients had no evidence of left-sided disease. Endoscopic and radiographic study findings and timing in relation to the manometry study were recorded. Anorectal manometry was performed by the standard protocol and included rectal sensory assessment, ability to expel a balloon, and pressure dynamics with simulated defecation.

RESULTS

Thirty IBD patients (Crohn's 23 patients; ulcerative colitis six patients) presented with defecatory disorders including constipation (67%) increased stooling (10%), and rectal urgency and/or incontinence and rectal pain (6%). All but one patient had anorectal manometric criteria of dyssynergia (presence of anismus motor pattern and inability to expel the balloon). Of the patients who completed biofeedback therapy, 30% had a clinically significant (≥7-point) improvement in SIBDQ score, with a reduction in health-care utilization after a six-month period (p=0.02).

CONCLUSIONS

Despite remission, some inflammatory bowel disease patients have persistent defecatory symptoms. Defecatory symptoms may not be predictive of an underlying inflammatory disorder. Lack of inflammatory activity and absence of left-sided disease should prompt investigation of functional disorders. Anorectal manometric testing and biofeedback therapy for patients with a diagnosis of dyssynergia may be a useful therapy.

摘要

背景

生物制剂在炎症性肠病(IBD)中的应用增加了疾病缓解的可能性。尽管活动性炎症得到了缓解,但仍有一部分 IBD 患者报告存在持续的排便症状。

目的

通过直肠肛门测压检查和随后的生物反馈治疗,评估一组疑似功能性排便障碍的炎症性肠病患者。

方法

本研究纳入了一组持续存在排便问题但临床症状改善的 IBD 患者。这些患者没有左侧疾病的证据。记录内镜和影像学检查结果以及与测压检查的时间关系。采用标准方案进行直肠肛门测压,包括直肠感觉评估、排空球囊的能力以及模拟排便时的压力动力学。

结果

30 例 IBD 患者(克罗恩病 23 例;溃疡性结肠炎 6 例)出现排便障碍,包括便秘(67%)、排便增多(10%)、直肠急迫感和/或失禁和直肠疼痛(6%)。除 1 例患者外,所有患者均存在肛门直肠测压异常的动力失调(存在痉挛性运动模式和排空球囊的能力不足)。在完成生物反馈治疗的患者中,30%的 SIBDQ 评分有显著改善(≥7 分),且在 6 个月后医疗保健利用率降低(p=0.02)。

结论

尽管炎症得到缓解,一些炎症性肠病患者仍存在持续的排便症状。排便症状可能无法预测潜在的炎症性疾病。缺乏炎症活动和左侧疾病的存在应促使对功能性疾病进行调查。对于诊断为动力失调的患者,直肠肛门测压检查和生物反馈治疗可能是一种有用的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验